I-WHO ihlaziye imeko yayo izikhokelo zokuphila kunyango lwe-COVID-19. Uhlaziyo lwesithoba olukhutshwe nge-03 Matshi 2022 lubandakanya isincomo esinemiqathango kwi-molnupiravir.
I-Molnupiravir iye yaba yi-antiviral yokuqala yomlomo iziyobisi ukuba ibandakanywe kwizikhokelo zonyango lwe-COVID-19. Njengoko eli liyeza elitsha, kukho idatha encinci yokhuseleko. Ke ngoko, i-WHO icebisa ukuba, i-molnupiravir kufuneka inikwe kuphela kwizigulana ezingekho bukhali ze-COVID-19 ngowona mngcipheko mkhulu wokulaliswa esibhedlele njengabantu abadala, abantu abane-immunodeficiencies kunye nabantu abaphila nezifo ezingapheliyo.
Akukho sincomo senziwe kwizigulane ezinezifo ezinzima okanye ezinzima njengoko kungekho datha yolingo i-molnupiravir kwaba bantu.
Abantwana, kunye nabasetyhini abakhulelweyo nabancancisayo akufanele banikwe ichiza.
Esi sindululo kusetyenziso olunemiqathango lwe-molnupiravir lusekwe kwidatha entsha esuka kumalingo amathandathu alawulwa ngokungakhethi buso abandakanya izigulane ezingama-4796. Le yeyona datha inkulu kweli chiza ukuza kuthi ga ngoku.
I-Molnupiravir ayifumaneki ngokubanzi kodwa amanyathelo athathiweyo ekwandiseni ufikelelo, kubandakanywa nokutyikitywa kwesivumelwano selayisenisi ngokuzithandela.
***
Iingxelo:
- WHO 2022. Ukukhutshwa kweendaba – i-WHO ihlaziya izikhokelo zayo zonyango ukuze ibandakanye i-monnupiravir. 3 Matshi 2022. Ifumaneka apha https://www.who.int/news/item/03-03-2022-molnupiravir
- Ziqhelanise neeNgcebiso eziKhawulezayo: Isikhokelo esiphilayo se-WHO kumachiza e-covid-19. Ipapashwe nge-04 Septemba 2020. ihlaziywe nge-3 Matshi 2022. BMJ 2020; 370 DOI: https://doi.org/10.1136/bmj.m3379
***
